TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
about
TUG1, SPRY4-IT1, and HULC as valuable prognostic biomarkers of survival in cancer: A PRISMA-compliant meta-analysis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
TUG1, SPRY4-IT1, and HULC as v ...... RISMA-compliant meta-analysis.
@en
TUG1, SPRY4-IT1, and HULC as v ...... RISMA-compliant meta-analysis.
@nl
type
label
TUG1, SPRY4-IT1, and HULC as v ...... RISMA-compliant meta-analysis.
@en
TUG1, SPRY4-IT1, and HULC as v ...... RISMA-compliant meta-analysis.
@nl
prefLabel
TUG1, SPRY4-IT1, and HULC as v ...... RISMA-compliant meta-analysis.
@en
TUG1, SPRY4-IT1, and HULC as v ...... RISMA-compliant meta-analysis.
@nl
P2093
P2860
P1433
P1476
TUG1, SPRY4-IT1, and HULC as v ...... RISMA-compliant meta-analysis.
@en
P2093
Haibiao Xie
Peixian Huang
Shuyuan Guo
Weiren Huang
Xinhui Liao
Yien Zheng
Yuchen Liu
Yucheng Zhong
P2860
P356
10.1097/MD.0000000000008583
P407
P577
2017-11-01T00:00:00Z